These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Immunomodulator in the study of rheumatoid arthritis (author's transl)]. Abe S. Ryumachi; 1978 Dec; 18(6):381-4. PubMed ID: 375429 [No Abstract] [Full Text] [Related]
4. [Levamisole -- a drug modifying immunologic phenomena]. Bogdanikowa B. Postepy Hig Med Dosw; 1979 Dec; 33(2):125-46. PubMed ID: 384382 [No Abstract] [Full Text] [Related]
5. [Treatment of rheumatoid arthritis with levamisole]. Schuermans Y, Cree J, Symoens J, Verhaegen H. Rev Rhum Mal Osteoartic; 1976 Jun; 43(6):437-40. PubMed ID: 781791 [No Abstract] [Full Text] [Related]
6. [Hypothesis for the use of levamisole in rheumatic diseases (author's transl)]. Symoens J. MMW Munch Med Wochenschr; 1977 Nov 18; 119(46):1501-4. PubMed ID: 414082 [Abstract] [Full Text] [Related]
7. [Use of levamisole, an immune controlling agent in various clinical conditions mainly liver diseases (author's transl)]. Miyake M. Fukuoka Igaku Zasshi; 1981 Jun 18; 72(6):368-78. PubMed ID: 6975743 [No Abstract] [Full Text] [Related]
8. [Discussion of the treatment of rheumatoid arthritis by levamisole (author's transl)]. Cottin S, Audran M, Jean Y. Therapie; 1979 Jun 18; 34(4):481-94. PubMed ID: 531780 [No Abstract] [Full Text] [Related]
9. [Principles of immunoregulation in autoimmune syndromes]. Skotnicki AB. Postepy Hig Med Dosw; 1983 Jun 18; 37(4):345-87. PubMed ID: 6233544 [No Abstract] [Full Text] [Related]
10. [Use of clinico-immunological indices for the evaluation of the efficacy of the basic therapy of rheumatoid arthritis]. Tsitlanadze VG, Dzidziguri LM, Tkemaladze LM, Kartvelishvili EIu, Shakulashvili NA. Ter Arkh; 1981 Jun 18; 53(7):72-4. PubMed ID: 6974910 [No Abstract] [Full Text] [Related]
11. [Immunostimulant therapy of kidney diseases]. Karastanev I. Vutr Boles; 1982 Jun 18; 21(3):8-13. PubMed ID: 6180558 [No Abstract] [Full Text] [Related]
12. [Various aspects of the mechanism of action of levamisole]. Chumakova MM. Ter Arkh; 1978 Jun 18; 50(9):146-53. PubMed ID: 360467 [No Abstract] [Full Text] [Related]
13. Levamisol in immunomodulative treatment of rheumatoid arthritis. Bogdanikowa B, Pietruska Z, Górska M, Stasiewicz A, Waszkiel B. Mater Med Pol; 1983 Jun 18; 15(1-2):15-9. PubMed ID: 6608642 [No Abstract] [Full Text] [Related]
14. [Tissue autoantibodies during therapy with levamisole for rheumatoid arthritis]. Cozzi F, Ruffatti A, Dalla Santa G, Dal Molin I, Fiocco U, Todesco S. Boll Soc Ital Biol Sper; 1982 Apr 15; 58(7):407-11. PubMed ID: 6979345 [Abstract] [Full Text] [Related]
15. [Current trends in the experimental therapy of autoimmune diseases]. Uteshev BS. Patol Fiziol Eksp Ter; 1981 Apr 15; (3):71-8. PubMed ID: 6456439 [No Abstract] [Full Text] [Related]
16. [Anti-inflammatory or antirheumatic agents? Pharmacological activity and therapeutic effectiveness of non-steroid anti-inflammatory drugs: comparative study. III]. Mariani L, Baratelli M. Clin Ter; 1980 Feb 29; 92(4):331-58. PubMed ID: 7004749 [No Abstract] [Full Text] [Related]
17. Prospects for B-cell-targeted therapy in autoimmune disease. Edwards JC, Cambridge G. Rheumatology (Oxford); 2005 Feb 29; 44(2):151-6. PubMed ID: 15509628 [No Abstract] [Full Text] [Related]
18. Levamisole and immunotherapy: some theoretic and practical considerations and their relevance to human disease. Amery WK, Gough DA. Oncology; 1981 Feb 29; 38(3):168-81. PubMed ID: 7010258 [Abstract] [Full Text] [Related]
19. [A case of rheumatoid arthritis associated with agranulocytosis during levamisole treatment (author's transl)]. Negishi M. Ryumachi; 1981 May 29; 21(3):227-33. PubMed ID: 7313900 [No Abstract] [Full Text] [Related]